Previous Article | Next Article ![]()
J Virol, July 1998, p. 5978-5983, Vol. 72, No. 7
Department of Medical Biochemistry and
Microbiology, BMC, Uppsala University, 751 23 Uppsala, Sweden
Received 31 December 1997/Accepted 21 April 1998
We have previously shown that the nonconserved carboxy-terminal
exon of the adenovirus type 2 E1A-289R protein contains two interchangeable sequence elements, auxiliary region (AR) 1 and AR2,
that are required for efficient CR3-mediated transcriptional activation
of the viral E4 promoter (M. Bondesson, C. Svensson, S. Linder, and G. Akusjärvi, EMBO J. 11:3347-3354, 1992). Here we show that
CR3-mediated transactivation of all adenovirus early promoters and the
HSP70 promoter requires the AR1 element. We further show that AR2 can
substitute for AR1 only when artificially juxtaposed to CR3. AR1
consists of six tandem glutamic acid-proline (EP) repeats and is
positioned immediately downstream of CR3. Genetic dissection of AR1
showed that the number of EP repeats in AR1 is critical for CR3
function. Thus, reducing or increasing the number of EP repeats reduces
the CR3 transactivation capacity. Furthermore, the introduction of
amino acid substitutions into AR1 suggested that the net negative
charge in AR1 is of critical importance for its function as an enhancer
of CR3-mediated transcriptional activation. Using an in vitro binding
approach, we showed that the AR1 element is not part of the CR3
promoter localization signal mediating contact with the Sp1, ATF-2, or
c-Jun upstream-binding transcription factors. Previous studies have
suggested that the 49-amino-acid sequence constituting CR3 represents
the minimal domain required for E1A-induced activation of viral early
promoters. Since AR1 was required for efficient CR3-mediated
transcriptional activation of all tested promoters, we suggest that the
carboxy-terminal boundary for the CR3 transactivation domain should be
extended to include the AR1 element.
The adenovirus E1A gene encodes a
family of structurally related proteins that are required to activate
all viral early promoters during lytic virus growth (for reviews, see
references 11 and 29). The two
major E1A proteins, of 289 and 243 amino acids (E1A-289R and E1A-243R,
respectively), are translated from the two most abundant E1A mRNAs, the
13S and 12S mRNAs, respectively. The E1A-289R protein contains three
conserved amino acid regions, designated CR1, CR2, and CR3
(18). Genetic studies have shown that these regions are
responsible for most of the activities ascribed to E1A in
transcriptional control and transformation (3, 29).
E1A activates transcription through several different mechanisms
which involve all three conserved domains (for a review, see
reference 2). However, the classical E1A
transcription activation domain is contained within CR3 and is
therefore unique to the E1A-289R protein. This domain has
been shown to participate in transcription activation by physically
interacting with both basal (i.e., TATA-binding protein [TBP]) and
upstream-binding transcription factors such as the ATF family of
transcription factors, c-Jun, Sp1, upstream stimulatory factor (USF),
CCAAT box binding factor, and Oct4/Oct3 (1, 7, 13, 22, 23, 28). In addition, it has been demonstrated that several
TBP-associated factors (Drosophila TAF110 and human
TAF135, TAF250, and TAF55) complex with the CR3 region of E1A (8,
12, 24, 25). It has been suggested that once E1A is anchored to
the promoter region via the promoter-targeting signal located at the
carboxy terminus of CR3, the amino-terminal activation domain of CR3
triggers preinitiation complex formation through an interaction with
TBP (20, 22, 23, 35). E1A would then make simultaneous
contact with sequence-specific DNA-binding transcription factors and
the basal transcription machinery. E1A-289R also activates
transcription by inducing phosphorylation of certain cellular
upstream-binding transcription factors, such as E4F (10, 26)
and TFIIIC (17).
We previously showed that efficient E1A-289R transactivation of the
viral E4 promoter requires one of the two interchangeable auxiliary
regions encoded by the nonconserved C-terminal exon of E1A (designated
AR1 and AR2 in reference 5). Here we show that AR1
is of general importance, being required for CR3-induced activation of
all tested promoters. Thus, we propose that the carboxy-terminal
boundary for the minimal CR3 transactivation domain should be extended
to include AR1. A genetic dissection of the adenovirus type 2 (Ad2) AR1
element (six glutamic acid-proline [EP] repeats) demonstrated that
the primary sequence of AR1 is not important for its function. Thus,
changing EP repeats to DP repeats resulted in a functional E1A
transactivator protein, whereas replacement of EP repeats with AP or KP
repeats inactivated AR1. Furthermore, the prolines in the EP repeat can
be replaced with glycine residues without having much of an effect on
AR1 function. Most likely, the significant feature of AR1 is its
presentation of a net negative charge. Although AR1 is juxtaposed to
the CR3 promoter localization signal in the wild-type protein, it was found not to be required for E1A interaction with cellular
upstream-binding transcription factors in vitro in glutathione
S-transferase (GST) pull-down experiments.
Plasmid DNA.
Plasmids pKGO-007SVRI (33) (referred
to as wtE1A in Fig. 2 and 3) and E1A deletion mutants D^X and D^Dr
(21), E/P
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
AR1 Is an Integral Part of the Adenovirus Type
2 E1A-CR3 Transactivation Domain
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
, and 6E/P (previously named
E/P+ in reference 5) have been described
previously. Mutants 4E/P, 8E/P, and 10E/P, which contain a reduced or
increased number of EP repeats compared to the wild-type E1A protein
(which has six EP repeats), were generated by PCR amplification with
appropriately designed primers. In 4E/P, wtE1A residues 197 to 245 were
replaced with the sequence ARG; in 8E/P and 10E/P, residues 201 to 245 were replaced with EPEPARG and EPEPEPEPARG, respectively. The PCR
mutants 4D/P, 4E/G, 4A/P, and 4K/P contain amino acid substitutions in
AR1. In 4D/P, wtE1A residues 193 to 245 were replaced with DPDPDPDPARG;
in 4E/G, residues 193 to 245 were replaced with EGEGEGE GARG; and in
4A/P and 4K/P, residues 193 to 245 were replaced with APA PAPAPARG and KPKPKPKPARG, respectively. In AR1mut, residues 193 to 203 were
replaced with APAPAPAPARG, generating a protein containing a mutated
AR1 region in the context of the full-length E1A-289R protein.
, 6E/P, and D^X were also introduced into
vector pML005 (referred to as wtE1A in Fig. 1). This plasmid is
identical to pKGO-007SVRI (33) except that it lacks the E1B
coding sequences and the simian virus 40 enhancer (4). The
cDNA clone encoding the E1A-243R protein (previously named pML00512S)
has been described elsewhere (30). The reporter plasmids
E1ACAT (15), E1BCAT (9), E2CAT(p2CAT)
(36), E3CAT (pKCAT23) (36), and E4CAT (20) have previously been described. The reporter plasmid
HSP70Luc (kindly provided by C. Svensson) consists of the HSP70
promoter fused to a luciferase reporter gene.
1-120), T7-6E/P (
1-120), T7-E/P
(
1-120), T7-243R (
1-120), and T7-CR3pt
(
1-120), encoding amino-terminally truncated E1A proteins, were generated by cDNA cloning, using an RNA PCR kit from Perkin-Elmer, or
by standard PCR amplification with appropriately designed primers. The
cDNAs were inserted into the pRSET-B vector (Invitrogen). The
T7-CR3pt
(
1-120) mutant, which bears a deletion of 15 amino acids (CGMFVYSPVSEPEPE) covering the CR3 promoter-targeting
region, was generated from E1a(
179-193) (22).
Transfections and CAT assay. HeLa cells were maintained in Dulbecco modified Eagle medium supplemented with 10% newborn calf serum. One hour before the cells were transfected, the medium was changed to Dulbecco modified Eagle medium containing 10% fetal calf serum. Cells were cotransfected with 1 µg of reporter plasmid and 0.1 to 1 µg of activator plasmid by the calcium phosphate coprecipitation technique (37). The amount of E1A activator plasmid was titrated so that equal E1A protein expression was detected by Western blot analysis. Therefore, wild-type E1A (wtE1A), 8E/P, and 10E/P were transfected with 0.1 µg of plasmid DNA, whereas all other E1A mutants were transfected with 1 µg. pUC19 DNA was added to a total of 15 µg of DNA per 60-mm-diameter dish. Eight to 12 h after transfection, cells were treated with 15% glycerol in HBS buffer (160 mM NaCl, 25 mM HEPES [pH 7.1], and 0.75 mM NH2PO4). Cells were harvested 48 h posttransfection and lysed by three consecutive freeze-thawing cycles, and the extract was used to measure chloramphenicol acetyltransferase (CAT) activity (32). Quantitative results were obtained by PhosphorImager scanning.
Transfections and luciferase assay. The effect of E1A mutants on HSP70 gene transcription was assayed on an HSP70-luciferase reporter plasmid (HSP70Luc). HeLa cells were grown in 35-mm-diameter petri dishes and cotransfected with 0.05 µg of reporter plasmid and 0.05 or 0.1 µg of activator plasmid, using the FuGENE6 transfection reagent (Boehringer-Mannheim). Forty-eight hours posttransfection, the cells were lysed and luciferase activity was assayed by using a luciferase assay system (Promega) as described by the manufacturer. Luciferase emissions were quantified with a luminometer (Labsystems Luminoscan).
GST protein binding analyses.
35S-labelled E1A
proteins were synthesized by using the T7-E1A variant plasmids
described above in a coupled in vitro transcription-translation reticulocyte lysate system (Promega). Synthesis conditions were those
recommended by the manufacturer, except that 100 µM ZnCl2 was included. GST fusion proteins were expressed in Escherichia coli and bound to glutathione-Sepharose beads. Protein
concentrations were estimated from Coomassie-stained sodium dodecyl
sulfate (SDS)-polyacrylamide gels. Approximately 10 µg of each GST
fusion protein was incubated with 10 µl of precleared
35S-labelled E1A protein. The binding reactions were
performed in a total volume of 50 µl in binding buffer (10 mM Tris,
0.15 M NaCl, 1.5 mM MgCl2, 0.1% Nonidet P-40, 0.1 mM
ZnCl2, and 20 mM
-mercaptoethanol) for 1 h on ice.
The beads were washed three times with 1 ml of binding buffer, and
interacting proteins were separated on an SDS-12% polyacrylamide gel
and visualized by autoradiography.
Analysis of E1A protein expression by Western blotting. Approximately one-third of each supernatant extract prepared from transfected cells (see above) were separated on an SDS-12% polyacrylamide gel and transferred to a Protran BA85 membrane (Schleicher & Schuell). Blots were probed with M73 monoclonal antibody (diluted 1:1,000; Oncogene Research Products), directed against the E1A carboxy terminus. E1A proteins were detected by the enhanced chemiluminescence technique as described by the manufacturer (New England BioLabs).
| |
RESULTS |
|---|
|
|
|---|
AR1 is essential for efficient E1A transactivation of early viral promoters. It has previously been demonstrated that two interchangeable elements, AR1 and AR2, are essential for efficient CR3-mediated transcriptional activation of the viral E4 promoter (5). Here, we analyzed whether the AR elements are of general importance for E1A-289R transactivation of other adenovirus promoters. Therefore, the transactivation capacity of E1A mutant proteins (Fig. 1A), lacking one or both AR elements, was measured in a transient transfection assay in HeLa cells. As a reporter we used the CAT gene cloned under the transcriptional control of one of the adenovirus early promoters, E1A, E1B, E2, E3, or E4. To obtain accurate results reflecting the transactivation capacity of E1A wild-type and mutant proteins, much care was taken to normalize E1A protein expression by titrating the amount of plasmid required for equal E1A protein expression (Fig. 1C) (see Materials and Methods). In this and all subsequent experiments, the levels of E1A protein expression in transfected cells were similar.
|
AR1 is essential for E1A-CR3 transactivation of the cellular HSP70 promoter. To determine whether AR1 is of general significance for CR3-mediated transactivation, the capacity of E1A mutant proteins (Fig. 1A) to activate transcription of the HSP70Luc reporter plasmid was tested. This promoter has previously been shown to be activated by both the E1A-289R and E1A-243R proteins (1, 19, 38). However, under our experimental conditions, the E1A-243R protein did not activate HSP70 transcription (Fig. 1B). In contrast, wtE1A (pML005) cotransfection resulted in an approximately 20-fold stimulation of HSP70 transcription. Deletion of both AR elements (D^Dr) completely abolished E1A activation. Cotransfection of plasmids encoding AR1 (6E/P) or AR2 (D^X) restored the activation capacity of E1A, with AR1 rescuing transactivation with a much higher efficiency. Similar to our findings with the viral promoters, AR2 does not functionally substitute for AR1 at its natural position (AR1mut).
The number of EP repeats in AR1 is critical for E1A transactivation. To define the significant functional feature of AR1 for E1A transcriptional activation, mutant plasmids expressing E1A proteins with reduced or increased EP repeat length were constructed (Fig. 2). The abilities of these mutant proteins to activate transcription of the E4-CAT reporter plasmid were determined in transiently transfected HeLa cells. As shown in Fig. 2, reducing the number of EP repeats from six to four resulted in an approximately 50% reduction of the E1A transactivation capacity. Further reduction of EP repeats, from four to two or zero, essentially abolished the effect of AR1 on E1A transactivation. This suggests that the number of EP repeats in AR1 is of critical importance for E1A transactivation. Interestingly, increasing the EP repeat length from 6 to 8 or 10 did not result in superactivation of E4 transcription; rather, we observed a reduction of the stimulatory effect of AR1.
|
The acidic nature of AR1 is required for its function. Although AR1 is essential for efficient transactivation by the Ad2 E1A protein, it is not well conserved among E1A proteins from other adenovirus serotypes (see Discussion). Also, AR2 substitutes for AR1 when artificially juxtaposed to CR3 (Fig. 1B). It is noteworthy that AR1 and AR2 do not show primary sequence homology. However, both regions are predicted to expose an acidic surface (5). Thus, the negative charge in AR1 might be the sequence feature required for enhancement of CR3 transactivation.
To test this hypothesis, plasmids expressing E1A mutant proteins with conservative or nonconservative amino acid substitutions in AR1 were constructed. As shown in Fig. 3, replacing four of the six glutamic acid residues in the EP repeat unit with aspartic acid (4D/P) resulted in a functional E1A transactivator protein. In contrast, substituting alanine (4A/P) or the positively charged amino acid lysine (4K/P) for glutamic acid either annulled or repressed E1A transactivation below the basal level of promoter activity (4A/P and 4K/P, respectively). Interestingly, replacement of four of the six prolines in the EP repeat unit with glycine was found to generate a functional E1A transactivator protein.
|
AR1 is not part of the CR3 promoter-targeting signal. Although all promoters tested in this study require AR1 for efficient E1A activation, they do not share a binding site for a common upstream-binding transcription factor. The promoters tested contain binding sites for multiple unrelated transcription factors that are E1A responsive (29).
One mechanism by which E1A has been shown to activate transcription is via recruitment to responsive promoters through an association with sequence-specific upstream-binding transcription factors (7, 13, 22, 23, 28). Several factors, such as c-Jun, ATF-2, and Sp1, have been shown to specifically interact with E1A via the promoter-targeting signal, located at the C terminus of CR3 (22). It is noteworthy that AR1 is located immediately downstream of the CR3 promoter-targeting signal. To investigate whether AR1 helps to direct the binding of transcription factors to CR3, a series of in vitro protein binding experiments was performed. For these experiments, GST, GST/c-Jun, GST/ATF-2, and GST/Sp1(DBD) fusion proteins were expressed in E. coli. Their abilities to bind in vitro-translated 35S-labelled E1A proteins (Fig. 4A) were tested in a standard GST pull-down assay. As shown in Fig. 4B, E1A (
1-120)
(wild type) and 6E/P (
1-120) (AR1+) bound strongly to
Sp1 and weakly to ATF-2 and c-Jun. The GST fusion proteins also bound
efficiently to E/P
(
1-120) (AR
),
suggesting that the interactions were AR independent. Importantly, none
of the transcription factors bound to the 243R (
1-120) protein, demonstrating that the interactions were CR3 dependent. Moreover, Sp1,
ATF-2, and c-Jun interactions with the CR3pt
(
1-120)
protein were drastically reduced, suggesting that the CR3
promoter-targeting signal (20, 35) is required for a stable interaction with E1A. Taken together, these results suggest that, at
least in vitro, AR1 is dispensable for interaction of E1A with upstream-binding transcription factors and, thus, does not appear to be
part of the E1A promoter-targeting signal.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have previously shown that two interchangeable elements in the nonconserved Ad2 E1A C-terminal exon (AR1 and AR2) are required for CR3-mediated transactivation of the viral E4 promoter (5). Here we extended this study by showing that AR1 is an essential element required for efficient E1A activation of all viral early promoters and the cellular HSP70 promoter (Fig. 1B). These results suggest that AR1 may be of global importance for CR3-mediated transactivation. Since the six EP repeats constituting AR1 are of general importance for E1A activation of transcription, we propose that the CR3 transactivation domain should be extended to include AR1.
We also showed that AR2 functionally imitates AR1 only when artificially juxtaposed to CR3 (Fig. 1B). Thus, in the wild-type E1A-289R protein, AR2 is nonfunctional as a CR3 enhancer domain, suggesting that the stimulatory effect of AR2 on CR3-mediated transactivation is artifactual. In contrast, AR2 appears to serve a biologically significant function in E1A transformation. Thus, AR2 has been shown to suppress the invasive propensity of E1A-transformed cells by inhibiting expression of metalloproteases (21). Consequently, AR1 and AR2 may both be biologically important elements, promoting different aspects of E1A biology.
On the basis of the great significance of Ad2 AR1 for CR3 transactivation, it appears likely that E1A proteins from other adenovirus serotypes also contain AR1-like elements. Since the primary sequence of AR1 is not well conserved among E1A proteins from other serotypes (Fig. 5), we designed experiments to identify the attributes of AR1 that are important for its function. In summary, these experiments suggest that the primary sequence of AR1 is not essential for its function. More likely, the net negative charge in AR1 is critical for its function as a CR3 enhancer. The number of EP repeats appears to be important, with six negative amino acids being optimal (Fig. 2). However, glutamic acid does not appear to be essential, since four of the six glutamic acids could be replaced by aspartic acids and still generate a functional E1A protein (Fig. 3). Also, four of the six prolines could be replaced with glycine without having much of an effect on AR1 function. Interestingly, replacing glutamic acid in AR1 with the basic amino acid lysine converted CR3 from a transcriptional activator to a transcriptional repressor domain. Additional support for our hypothesis that the net negative charge of AR1 is critical for function comes from an independent study by Webster and Ricciardi (35). They showed that the glutamic acid and proline of the first EP repeat could be individually replaced with aspartic acid and glycine, respectively, without CR3 transactivation being negatively affected. Also, AR2, which exhibits no primary sequence homology with AR1, substitutes for AR1 with a high efficiency when artificially juxtaposed to CR3 (Fig. 1B). AR2 has been mapped to a 23-amino-acid serine-threonine-rich region (5), of which many residues appear to be phosphorylated in vivo (34). Thus, the common denominator in AR1 and AR2 appears to be their acidic character. Collectively, these results strongly suggest that negative charges positioned next to CR3 are a prerequisite for efficient E1A activation of transcription. Although acidic regions are reported to function as transcriptional activation domains, AR1 did not function as such in a Gal4-E1A fusion protein assay (5).
|
With this limited genetic dissection of the Ad2 AR1 element, we searched for potentially homologous elements in E1A proteins from other serotypes. As shown in Fig. 5, all E1A proteins appear to have an excess of negatively charged amino acids positioned immediately downstream of the highly conserved C-terminal end of CR3. In some cases, the potential AR1 region is rich in serine residues, which theoretically may be phosphorylated in vivo. Our analysis suggests that a minimum of four negatively charged amino acids are required to create an E1A protein with a reasonable transactivation capacity (Fig. 2). Such a criterion appears to be fulfilled in all serotypes. Thus, it is possible that AR1-homologous elements exist in other E1A proteins.
Little is known about the mechanism by which AR1 enhances CR3-mediated
transactivation. Our results showed that AR1 is essential for efficient
CR3 transactivation in the context of the E1A wild-type protein.
However, artificial tethering of CR3 to a promoter via the Gal4 DNA
binding domain makes CR3 transactivation essentially AR independent
(6). These results are consistent with the hypothesis that
AR1 is required for recruitment of E1A to upstream-binding transcription factors. It is noteworthy that AR1 is positioned immediately downstream of the highly conserved promoter-targeting signal at the C-terminal end of CR3 (20, 35). This region has previously been shown to bind several transcription factors, such
as c-Jun, ATF-2, Sp1, and USF (22). Thus, the most obvious hypothesis is that AR1 is required for interaction of CR3 with upstream-binding transcription factors. As shown in Fig. 4B,
interaction of E1A with Sp1, ATF-2, or c-Jun required CR3 (243R) and
was dependent on the CR3 promoter-targeting signal
(CR3pt
). It is also noteworthy that these interactions
were not enhanced by AR1 (compare the results for E/P+ and
E/P
). Our results, therefore, are compatible with the
hypothesis that AR1 is not part of the CR3 promoter-targeting signal.
However, we cannot exclude the possibility that AR1 may help recruit
transcription factors to CR3 in vivo, a stimulatory activity that is
not reproduced in vitro in GST pull-down assays.
We have also considered the possibility that AR1 is selectively required for E1A activation through induced transcription factor phosphorylation. Thus, we previously showed that E1A induction of E4 promoter activity is primarily mediated by the cellular E4F transcription factor. Since E1A activation of E4F appears to involve an E1A-induced phosphorylation of E4F (10, 27), we previously hypothesized that the AR elements might be selectively required for E1A transactivation through transcription factor phosphorylation (5). However, our demonstration that AR1 is required for E1A activation of the HSP70 promoter and all adenovirus early promoters, most which are not believed to be regulated through transcription factor phosphorylation, argues against this hypothesis. E1A does not have an intrinsic protein kinase activity, but the CR3 domain has recently been found to associate with a cellular CTD (C-terminal domain of the largest subunit of RNA polymerase II) protein kinase (14, 16). We have therefore tested whether AR1 enhances CTD phosphorylation. Although we detected an E1A-associated CTD kinase activity, its binding to E1A was not dependent on the presence of AR1 (data not shown).
In summary, our results suggest that AR1 is an integral part of the CR3 transactivation domain, essential for Ad2 E1A transactivation of all tested promoters. However, the function of AR1 in E1A transactivation remains elusive.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to C. Svensson, K. Sollerbrant, and M. Green for kind gifts of plasmids. We also thank M. Mannervik for helpful comments on the manuscript.
This work was supported by the Swedish Cancer Society.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Dept. of Medical Biochemistry and Microbiology, BMC, Uppsala University, Box 582, 751 23 Uppsala, Sweden. Phone: (46) 18-471 4164. Fax: (46) 18-509 876. E-mail: goran.akusjarvi{at}imim.uu.se.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Agoff, S. N., and B. Wu. 1994. CBF mediates adenovirus E1a trans-activation by interaction at the C-terminal promoter targeting domain of conserved region 3. Oncogene 9:3707-3711[Medline]. |
| 2. | Akusjärvi, G. 1993. Proteins with transcription regulatory properties encoded by human adenoviruses. Trends Microbiol. 1:163-170[Medline]. |
| 3. | Bayley, S. T., and J. S. Mymryk. 1994. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5:425-444. |
| 4. |
Bondesson, M.,
M. Mannervik,
G. Akusjärvi, and C. Svensson.
1994.
An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter.
Nucleic Acids Res.
22:3053-3060 |
| 5. | Bondesson, M., C. Svensson, S. Linder, and G. Akusjärvi. 1992. The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J. 11:3347-3354[Medline]. |
| 6. | Bondesson, M., K. Öhman, M. Mannervik, S. Fan, and G. Akusjärvi. 1996. Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter. J. Virol. 70:3844-3851[Abstract]. |
| 7. |
Chatton, B.,
J. L. Bocco,
M. Gaire,
C. Hauss,
B. Reimund,
J. Goetz, and C. Kedinger.
1993.
Transcriptional activation by the adenovirus larger E1a product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1a.
Mol. Cell. Biol.
13:561-570 |
| 8. |
Chiang, C. M., and R. G. Roeder.
1995.
Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators.
Science
267:531-536 |
| 9. | Dery, C. V., C. H. Herrmann, and M. B. Mathews. 1987. Response of individual adenovirus promoters to the products of the E1A gene. Oncogene 2:15-23[Medline]. |
| 10. |
Fernandes, E. R., and R. J. Rooney.
1997.
The adenovirus E1A-regulated transcription factor E4F is generated from the human homolog of nuclear factor AP3.
Mol. Cell. Biol.
17:1890-1903[Abstract].
|
| 11. | Flint, J., and T. Shenk. 1989. Adenovirus E1A protein paradigm viral transactivator. Annu. Rev. Genet. 23:141-161[Medline]. |
| 12. | Geisberg, J. V., J.-L. Chen, and R. P. Ricciardi. 1995. Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex. Mol. Cell. Biol. 15:6283-6290[Abstract]. |
| 13. |
Geisberg, J. V.,
W. S. Lee,
A. J. Berk, and R. P. Ricciardi.
1994.
The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein.
Proc. Natl. Acad. Sci. USA
91:2488-2492 |
| 14. |
Gold, M. O.,
J. P. Tassan,
E. A. Nigg,
A. P. Rice, and C. H. Herrmann.
1996.
Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.
Nucleic Acids Res.
24:3771-3777 |
| 15. | Herrmann, C. H., C. V. Dery, and M. B. Mathews. 1987. Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen. Oncogene 2:25-35[Medline]. |
| 16. |
Herrmann, C. H.,
M. O. Gold, and A. P. Rice.
1996.
Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain.
Nucleic Acids Res.
24:501-508 |
| 17. | Hoeffler, W. K., R. Kovelman, and R. G. Roeder. 1988. Activation of transcription factor IIIC by the adenovirus E1A protein. Cell 53:907-920[Medline]. |
| 18. |
Kimelman, D.,
J. S. Miller,
D. Porter, and B. E. Roberts.
1985.
E1a regions of the human adenoviruses and of the highly oncogenic simian adenovirus 7 are closely related.
J. Virol.
53:399-409 |
| 19. |
Kraus, V. B.,
E. Moran, and J. R. Nevins.
1992.
Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains.
Mol. Cell. Biol.
12:4391-4399 |
| 20. | Lillie, J. W., and M. R. Green. 1989. Transcription activation by the adenovirus E1a protein. Nature 338:39-44[Medline]. |
| 21. | Linder, S., P. Popowicz, C. Svensson, H. Marshall, M. Bondesson, and G. Akusjärvi. 1992. Enhanced invasive properties of rat embryo fibroblasts transformed by adenovirus E1A mutants with deletions in the carboxy-terminal exon. Oncogene 7:439-443[Medline]. |
| 22. | Liu, F., and M. R. Green. 1994. Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368:520-525[Medline]. |
| 23. | Liu, F., and M. R. Green. 1990. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein. Cell 61:1217-1224[Medline]. |
| 24. | Mazzarelli, J. M., G. B. Atkins, J. V. Geisberg, and R. P. Ricciardi. 1995. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110. Oncogene 11:1859-1864[Medline]. |
| 25. | Mazzarelli, J. M., G. Mengus, I. Davidson, and R. P. Ricciardi. 1997. The transactivation domain of adenovirus E1A interacts with the C terminus of human TAFII135. J. Virol. 71:7978-7983[Abstract]. |
| 26. |
Raychaudhuri, P.,
S. Bagchi, and J. R. Nevins.
1989.
DNA-binding activity of the adenovirus-induced E4F transcription factor is regulated by phosphorylation.
Genes Dev.
3:620-627 |
| 27. |
Rooney, R. J.,
P. Raychaudhuri, and J. R. Nevins.
1990.
E4F and ATF, two transcription factors that recognize the same site, can be distinguished both physically and functionally: a role for E4F in E1A trans activation.
Mol. Cell. Biol.
10:5138-5149 |
| 28. | Scholer, H. R., T. Ciesiolka, and P. Gruss. 1991. A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells. Cell 66:291-304[Medline]. |
| 29. | Shenk, T., and J. Flint. 1991. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57:47-85[Medline]. |
| 30. |
Sollerbrant, K.,
G. Akusjärvi, and C. Svensson.
1993.
Repression of RNA polymerase III transcription by adenovirus E1A.
J. Virol.
67:4195-4204 |
| 31. |
Ström, A. C.,
M. Forsberg,
P. Lillhager, and G. Westin.
1996.
The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression.
Nucleic Acids Res.
24:1981-1986 |
| 32. | Svensson, C., and G. Akusjärvi. 1990. A novel effect of adenovirus VA RNA1 on cytoplasmic mRNA abundance. Virology 174:613-617[Medline]. |
| 33. | Svensson, C., U. Pettersson, and G. Akusjärvi. 1983. Splicing of adenovirus 2 early region 1A mRNAs is non-sequential. J. Mol. Biol. 165:475-495[Medline]. |
| 34. |
Tremblay, M. L.,
C. J. McGlade,
G. E. Gerber, and P. E. Branton.
1988.
Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments.
J. Biol. Chem.
263:6375-6383 |
| 35. |
Webster, L. C., and R. P. Ricciardi.
1991.
trans-Dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor.
Mol. Cell. Biol.
11:4287-4296 |
| 36. |
Weeks, D. L., and N. C. Jones.
1983.
E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.
Mol. Cell. Biol.
3:1222-1234 |
| 37. | Wigler, M., A. Pellicer, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14:725-731[Medline]. |
| 38. |
Wu, B. J.,
H. C. Hurst,
N. C. Jones, and R. I. Morimoto.
1986.
The E1A 13S product of adenovirus 5 activates transcription of the cellular human HSP70 gene.
Mol. Cell. Biol.
6:2994-2999 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»